Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis

Published:2023-08 Issue: Volume:145 Page:155612
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Chun Hye Jin,Kim Eun Ran,Lee Minyoung,Choi Da Hyun,Kim Soo Hyun,Shin Eugene,Kim Jin-Hong,Cho Jin Won,Han Dai Hoon,Cha Bong-Soo,Lee Yong-ho

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference57 articles.

1. Nonalcoholic fatty liver disease 2020: the state of the disease;Cotter;Gastroenterology,2020

2. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

3. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J Hepatol,2020

4. Metabolic dysfunction-associated fatty liver disease and mortality: a population-based cohort study;Kim;Diabetes Metab J,2023

5. Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a position statement of the fatty liver research Group of the Korean Diabetes Association;Lee;Diabetes Metab J,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could the administration of SGLT2i agents serve as a viable prophylactic approach against CNI-induced toxicities?;Medical Hypotheses;2024-08

2. Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials;Journal of Gastroenterology;2024-07-26

3. Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches;Antioxidants;2024-07-26

4. O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36;Metabolism;2024-07

5. Defining omics-based biomarker signatures of metabolic dysfunction-associated steatotic liver disease (MASLD): In vitro studies;Current Opinion in Biomedical Engineering;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3